Table 1.
Baseline characteristics of participants in the Prospective Investigation of the Vasculature in Uppsala Seniors study
| Variable | |
|---|---|
| Number of subjects | 1003 |
| Female no. (%) | 497 (50) |
| Age (yr) | 70.2±0.2 |
| Body mass index (kg/m2) | 27±4 |
| Systolic BP (mmHg) | 150±23 |
| Diastolic BP (mmHg) | 79±10 |
| Serum total cholesterol (mg/dl) | 5.4±1.0 |
| Serum HDL cholesterol (mg/dl) | 1.5±0.4 |
| Fasting plasma glucose (mg/dl) | 5.3±1.6 |
| Diabetes | 117 (12) |
| Smoking no. (%) | 109 (11) |
| Previous cardiovascular disease no. (%) | 164 (16) |
| Lipid-lowering treatment no. (%) | 159 (16) |
| Antihypertensive treatment no. (%) | 314 (31) |
| Estimated GFR (ml/min per 1.73 m2) | 80±14 |
| Serum calcium (mg/dl) | 9.44±0.52 |
| Serum phosphate (mg/dl) | 3.40±0.53 |
| Serum 25(OH)D3 (nmol/L) | 58±20 |
| Serum intact PTH (pmol/L) | 47±21 |
| Serum FGF23 (pg/ml) | 47±24 |
| Left ventricular mass (g) | 225±75 |
| Left ventricular ejection fraction (%) | 66±8 |
| Endothelium-dependent vasodilatation (%) | 529±316 |
| Endothelium-independent vasodilatation (%) | 369±213 |
| Flow-mediated dilatation (%) | 4.8±3.6 |
| Pulse-wave reflection index (%) | −31±14 |
| Intima media thickness (mm) | 0.92±0.16 |
Data are mean ± SD for continuous variables and n (%) for categorical variables. 25(OH)D3, 25-hydroxyvitamin D3; PTH, parathyroid hormone; FGF23, fibroblast growth factor-23.